[go: up one dir, main page]

CU23400A1 - Método para la obtención de minicírculos replicativos de adn para transferencia génica o como inmunomoduladores - Google Patents

Método para la obtención de minicírculos replicativos de adn para transferencia génica o como inmunomoduladores

Info

Publication number
CU23400A1
CU23400A1 CU20030098A CU20030098A CU23400A1 CU 23400 A1 CU23400 A1 CU 23400A1 CU 20030098 A CU20030098 A CU 20030098A CU 20030098 A CU20030098 A CU 20030098A CU 23400 A1 CU23400 A1 CU 23400A1
Authority
CU
Cuba
Prior art keywords
obtaining
gene transfer
immunomodulators
minicycles
replicative dna
Prior art date
Application number
CU20030098A
Other languages
English (en)
Spanish (es)
Inventor
Rodriguez Ernesto Galban
Dunn Alejandro Miguel Martin
Porto Marta Gloria Duenas
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Priority to CU20030098A priority Critical patent/CU23400A1/es
Priority to PCT/CU2004/000007 priority patent/WO2004096288A2/fr
Publication of CU23400A1 publication Critical patent/CU23400A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CU20030098A 2003-04-29 2003-04-29 Método para la obtención de minicírculos replicativos de adn para transferencia génica o como inmunomoduladores CU23400A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CU20030098A CU23400A1 (es) 2003-04-29 2003-04-29 Método para la obtención de minicírculos replicativos de adn para transferencia génica o como inmunomoduladores
PCT/CU2004/000007 WO2004096288A2 (fr) 2003-04-29 2004-04-26 Methode d'obtention de minicercles de replication d'adn destines au transfert genique ou utilises comme immunomodulateurs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20030098A CU23400A1 (es) 2003-04-29 2003-04-29 Método para la obtención de minicírculos replicativos de adn para transferencia génica o como inmunomoduladores

Publications (1)

Publication Number Publication Date
CU23400A1 true CU23400A1 (es) 2009-08-04

Family

ID=33315384

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20030098A CU23400A1 (es) 2003-04-29 2003-04-29 Método para la obtención de minicírculos replicativos de adn para transferencia génica o como inmunomoduladores

Country Status (2)

Country Link
CU (1) CU23400A1 (fr)
WO (1) WO2004096288A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006242387B2 (en) 2005-04-29 2011-01-06 Synthetic Genomics, Inc. Amplification and cloning of single DNA molecules using rolling circle amplification
WO2007021944A2 (fr) 2005-08-11 2007-02-22 The J. Craig Venter Institute Methode de recombinaison in vitro
US9125845B2 (en) * 2008-07-09 2015-09-08 General Electric Company DNA vaccines, uses for unprocessed rolling circle amplification product and methods for making the same
US20100008939A1 (en) * 2008-07-09 2010-01-14 General Electric Company Unprocessed rolling circle amplification product
US8921072B2 (en) * 2008-09-02 2014-12-30 General Electric Compnay Methods to generate DNA mini-circles
CA3250004A1 (fr) * 2022-04-29 2023-11-02 Theraphage Inc. Système d’administration d’acide nucléique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696278B1 (en) * 2001-02-26 2004-02-24 Stratagene Method for transfer of DNA segments

Also Published As

Publication number Publication date
WO2004096288A2 (fr) 2004-11-11
WO2004096288A3 (fr) 2004-12-09

Similar Documents

Publication Publication Date Title
DK2484758T3 (da) Rationelt konstruerede meganucleaser med ændret sekvensspecificitet og DNA-bindingsaffinitet
WO2019191341A8 (fr) Agents thérapeutiques à base d'acides nucléiques
AR059257A1 (es) Genes para mejorar la eficiencia de la utilizacion de nitrogeno en los cultivos
SV2018005781A (es) Proteinas de fusión gdf15 y usos de éstas
AR053370A1 (es) Anticuerpos anti-il-6 composiciones , metodos y usos
AR061662A1 (es) Grg33, grg35, grg36, grg37, grg38, grg39 y grg50: genes de epsp sintetasa que confieren resistencia a herbicidas
AR087366A1 (es) Gen plaguicida axmi 279 y sus metodos de empleo
MX2019012772A (es) Metodos y composiciones para la modificacion de adn objetivo dirigida por arn y para la modulacion de la transcripcion dirigida por arn.
DK2025756T3 (da) Forbedret målrettet DNA-indsætning i planter
BR112016007727A2 (pt) célula hospedeira, métodos para produzir um glicoconjugado, uma célula hospedeira e uma proteína n-glicosilada, para tratar ou prevenir uma infecção em um indivíduo e para induzir uma resposta imune em um indivíduo, glicoconjugado, kit, e, plasmídeo isolado
SG151315A1 (en) Human glp-1 mimetibodies, compositions, methods and uses
MX2019004487A (es) Metodos y composiciones para el tratamiento de la enfermedad de fabry.
AR061661A1 (es) Gen de epsp sintetasa que confiere resistencia a herbicidas
AR030236A1 (es) Moléculas similares a il-17 y usos de las mismas
WO2009076292A3 (fr) Méganucléases conçues rationnellement avec des séquences d'identification trouvées dans des régions hypersensibles à l'adnase du génome humain
EP3653730A4 (fr) Kit d'isolement d'adn acellulaire mutant et procédé d'isolement d'adn acellulaire mutant l'utilisant
MX2022005572A (es) Estrategias crispr y aav para la terapia de retinosquisis juvenil ligada al cromosoma x.
CU23400A1 (es) Método para la obtención de minicírculos replicativos de adn para transferencia génica o como inmunomoduladores
CO2021014015A2 (es) Sistemas de edición génica para modificar un gen scn9a o scn10a y métodos para su uso
DE60336124D1 (de) Gen-targeting mit replizierenden dna-molekülen
CL2018002900A1 (es) Construcciones de adn para la fabricación de polipéptidos bioterapéuticos para su uso en vacunas animales y agentes terapéuticos.
AR043862A1 (es) Procedimiento para la obtencion de estirpes celulares de mastocitos a partir de tejidos de cerdo y procedimiento para la produccion de moleculas de tipo de la heparina
ES2562919T3 (es) Proteína y secuencia de ADN que codifica una actividad del tipo de la subtilisina adaptada al frío
CL2021002213A1 (es) Formulación microbiana de intestino de abeja para su uso como un probiótico para salud mejorada y resistencia a patógenos de las abejas.
UY29544A1 (es) Tratamiento de enfermedades usando un sistema mejorado de expresión regulada